These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8546844)

  • 21. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
    Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
    J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferating cell nuclear antigen staining as a prognostic indicator in soft-tissue malignant fibrous histiocytoma.
    Sugiura H; Sato K; Yamamura S; Nagasaka T; Takahashi M; Katagiri H
    Arch Orthop Trauma Surg; 1995; 114(5):248-52. PubMed ID: 7577213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
    Steck K; el-Naggar AK
    Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.
    Heegaard S; Sommer HM; Broholm H; Broendstrup O
    Cancer; 1995 Nov; 76(10):1809-13. PubMed ID: 8625052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.
    Linden MD; Ma CK; Kubus J; Brown RD; Zarbo RJ
    Am J Clin Pathol; 1993 Sep; 100(3):206-12. PubMed ID: 8104388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
    Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M
    Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
    Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
    Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant fibrous histiocytoma. Proliferative compartment and heterogeneity of "histiocytic" cells.
    Iwasaki H; Yoshitake K; Ohjimi Y; Kikuchi M; Isayama T; Yoh S; Shinohara N; Enjoji M
    Am J Surg Pathol; 1992 Aug; 16(8):735-45. PubMed ID: 1353946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of differential nuclear expression of Ki-67 in adult soft tissue sarcomas].
    Rohr UP; Heinzinger M; Rheinländer B; Parwaresch R; Bohle RM
    Verh Dtsch Ges Pathol; 1998; 82():345-50. PubMed ID: 10095458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
    Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
    Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
    J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
    Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
    J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: relationship to histological grade and mitotic activity.
    Korkolopoulou P; Christodoulou P; Papanikolaou A; Tsenga A; Thomas-Tsagli E
    J Cancer Res Clin Oncol; 1994; 120(7):393-8. PubMed ID: 7910610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
    Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
    Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.